Related Experiment Video
Updated: Oct 18, 2025

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Impact of Left Ventricular Outflow Tract Calcification on Outcomes Following Transcatheter Aortic Valve Replacement
Anees Musallam1, Kyle D Buchanan2, Charan Yerasi1
1Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA.
Insights
Left ventricular outflow tract (LVOT) calcification increases paravalvular leak (PVL) risk after transcatheter aortic valve replacement (TAVR), even with advanced techniques. However, TAVR remains safe in these patients, with similar mortality and pacemaker rates.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Left ventricular outflow tract (LVOT) calcification is a known factor influencing outcomes after transcatheter aortic valve replacement (TAVR).
- Previous studies suggested increased mortality with severe LVOT calcification but used older valve generations and lacked robust calcification assessment methods.
Purpose of the Study:
- To evaluate the impact of LVOT calcification on outcomes following TAVR using contemporary transcatheter heart valves.
- To assess the relationship between quantified LVOT calcification and procedural/clinical outcomes.
Main Methods:
- Retrospective analysis of 273 patients undergoing TAVR between 2013-2017.
- LVOT calcification quantified as a continuous variable.
- Comparison of outcomes between patients with and without LVOT calcification, including valve types and use of balloon post-dilatation (BPD).
Main Results:
- Patients with calcified LVOT (LVOTCA) showed higher rates of paravalvular leak (PVL) at discharge (47.5% vs. 29.1%) despite increased use of BPD (31.3% vs. 19%).
- Contemporary valves like Evolut R were used more in LVOTCA, while Sapien 3 was more common in non-calcified LVOT (NOLVOTCA).
- All-cause mortality and pacemaker implantation rates were similar between groups.
Conclusions:
- Transcatheter aortic valve replacement (TAVR) is a safe procedure in patients with LVOT calcification.
- LVOT calcification is associated with an increased risk of paravalvular leak (PVL) post-TAVR.
- Quantification of calcium did not predict the degree of PVL, suggesting other factors may be involved.
Background:
We aimed to determine left ventricular outflow tract (LVOT) calcification impact following transcatheter aortic valve replacement (TAVR) with contemporary transcatheter heart valves. Recent studies reported a higher rate of 2-year mortality with greater than moderate LVOT calcium, but they have not established a reliable and validated method to assess the degree of valve calcification and utilized first-generation valves for their analyses.
Materials/Methods:
We conducted a retrospective analysis of patients who underwent TAVR at our institution from 2013 through 2017 with available valves. LVOT calcification quantification was assessed as a continuous variable.
Results:
We included 273 patients: 179 had a non-calcified LVOT (NOLVOTCA) and 96 had a calcified LVOT (LVOTCA). Balloon post-dilatation (BPD) was utilized in 31.3% of LVOTCA vs. 19% of NOLVOTCA (p = 0.029). The Evolut R valve was used in 40.6% vs. 23.4% (p = 0.002), while the Sapien 3 was used in 59.4% vs. 76.6% (p = 0.004), for the LVOTCA and NOLVOTCA, respectively. Paravalvular leak (PVL) at hospital discharge was higher in LVOTCA (47.5%) versus NOLVOTCA (29.1%; p = 0.004). All-cause mortality (11.5% vs. 10.1%; p = 0.5) and need for permanent pacemaker implantation were similar between the groups. There was a positive trend between LVOT calcification volume and the probability of any PVL (OR 1.012; 95% CI, 0.99-1.02).
Conclusions:
TAVR performed in patients with calcified LVOT is safe, but LVOT calcification adversely impacts TAVR outcomes, with a higher PVL rate despite greater usage of BPD. Calcium quantification did not predict any PVL degree post-TAVR.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Cardiac Catheterization III: Left Heart Catheterization

